He served for 17 years at the $5 billion clinical-laboratory company – Laboratory Corporation of America.

At LabCorp’s hospital, he recently served as senior vice president and was responsible for developing and implementing the hospital strategy.

Previously, he held full P&L responsibility for LabCorp’s anatomic pathology business – DIANON Systems.

StrataDx CEO Pat Noland said they have experienced impressive growth in other specialties due to their quality, expertise, and focus on the customer and patient.

"We look forward to expand those services beyond our core geographic market," Noland said.

StrataDx provides services in all areas of cytology and surgical pathology, as well as immunofluorescence and molecular diagnostics.